Special Issue "Recent Advances in Glucose Sensors"

A special issue of Biosensors (ISSN 2079-6374).

Deadline for manuscript submissions: closed (30 April 2014).

Special Issue Editor

Prof. Dr. Viola Birss
Website
Guest Editor
Department of Chemistry, University of Calgary, 2500 University Dr. N.W., Calgary, Alberta T2N 1N4, Canada
Interests: electrochemical sensors; glucose sensors; electrocatalysis; nanoparticles; nanotubes; fuel cells

Special Issue Information

Dear Colleagues,

A special issue of Biosensors, which is focused specifically on the topic of “Glucose Sensors”, will be published related to the massive challenge the world is facing in terms of diabetes. Diabetes is a chronic disease in which the body fails to maintain a blood sugar (glucose) level within the normal range. It is estimated that over 300 million people worldwide have diabetes, with this number accelerating rapidly. Diabetes often leads to many serious complications and thus is a leading cause of death. Therefore, a critical issue for those with diabetes is accurate glucose monitoring and treatment with the appropriate amounts of insulin or other drugs.

Blood glucose measurements have typically involved withdrawing a droplet of blood, followed by optical or electrochemical measurements. However, the drawbacks of this approach include pain, inconvenience, poor accuracy, etc. Implantable glucose sensors are also of interest, but these often suffer from lifetime (e.g., fouling) issues. Therefore, the focus of this special issue is on contributions that demonstrate new glucose sensing strategies, concepts, and designs, as well as improved understanding of sensor operation, with an emphasis on improved reliability, lifetime, continuous glucose monitoring, response time, accuracy, etc. Although the recent focus has been on the use of electrochemical methods, contributions involving spectroscopic methods or other novel and non-invasive sensing strategies are also welcome.

Dr. Viola Birss
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • continuous glucose monitoring
  • implantable glucose sensors
  • glucose sensor nanostructures
  • sensor protection from biofouling
  • glucose sensor/insulin platforms
  • non-enzymatic sensors
  • calibration and assessment criteria

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Open AccessReview
Recent Advances in Fluorescent Arylboronic Acids for Glucose Sensing
Biosensors 2013, 3(4), 400-418; https://doi.org/10.3390/bios3040400 - 10 Dec 2013
Cited by 15
Abstract
Continuous glucose monitoring (CGM) is crucial in order to avoid complications caused by change in blood glucose for patients suffering from diabetes mellitus. The long-term consequences of high blood glucose levels include damage to the heart, eyes, kidneys, nerves and other organs, among [...] Read more.
Continuous glucose monitoring (CGM) is crucial in order to avoid complications caused by change in blood glucose for patients suffering from diabetes mellitus. The long-term consequences of high blood glucose levels include damage to the heart, eyes, kidneys, nerves and other organs, among others, caused by malign glycation of vital protein structures. Fluorescent monitors based on arylboronic acids are promising candidates for optical CGM, since arylboronic acids are capable of forming arylboronate esters with 1,2-cis-diols or 1,3-diols fast and reversibly, even in aqueous solution. These properties enable arylboronic acid dyes to provide immediate information of glucose concentrations. Thus, the replacement of the commonly applied semi-invasive and non-invasive techniques relying on glucose binding proteins, such as concanavalin A, or enzymes, such as glucose oxidase, glucose dehydrogenase and hexokinases/glucokinases, might be possible. The recent progress in the development of fluorescent arylboronic acid dyes will be emphasized in this review. Full article
(This article belongs to the Special Issue Recent Advances in Glucose Sensors)
Show Figures

Graphical abstract

Back to TopTop